• 1
    Centers for Disease Control and Prevention. FastStats: Death and Mortality. Available at Accessed Mar 3, 2011.
  • 2
    Heron M, Hoyert DL, Murphy SL, et al. Deaths: final data for 2006. Natl Vital Stat Rep. 2009; 57:1134.
  • 3
    Lave JR. The cost of treating patients with community-acquired pneumonia. Semin Respir Crit Care Med. 1999; 20:18997.
  • 4
    Stanton M. Improving Treatment Decisions for Patients with Community-Acquired Pneumonia. Available at: Accessed Mar 3, 2011.
  • 5
    Pitts SR, Niska RW, Xu J, Burt CW. National Hospital Ambulatory Medical Care Survey: 2006 emergency department summary. Natl Health Stat Report. 2008:138.
  • 6
    U.S. Department of Health and Human Services. Hospital Compare Home. Available at: Accessed Mar 3, 2011.
  • 7
    The Joint Commission. Performance Measure Initiatives: Pneumonia Core Measure Set. Available at: Accessed Mar 3, 2011.
  • 8
    Kanwar M, Brar N, Khatib R, Fakih MG. Misdiagnosis of community-acquired pneumonia and inappropriate utilization of antibiotics: side effects of the 4-h antibiotic administration rule. Chest. 2007; 131:18659.
  • 9
    Wachter RM, Flanders SA, Fee C, Pronovost PJ. Public reporting of antibiotic timing in patients with pneumonia: lessons from a flawed performance measure. Ann Intern Med. 2008; 149:2932.
  • 10
    Yu KT, Wyer PC. Evidence-based emergency medicine/critically appraised topic. Evidence behind the 4-hour rule for initiation of antibiotic therapy in community-acquired pneumonia. Ann Emerg Med. 2008; 51:65162.
  • 11
    Pines JM, Isserman JA, Hinfey PB. The measurement of time to first antibiotic dose for pneumonia in the emergency department: a white paper and position statement prepared for the American Academy of Emergency Medicine. J Emerg Med. 2009; 37:33540.
  • 12
    Houck PM, Bratzler DW, Nsa W, Ma A, Bartlett JG. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med. 2004; 164:63744.
  • 13
    Meehan TP, Fine MJ, Krumholz HM, et al. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA. 1997; 278:20804.
  • 14
    Dedier J, Singer DE, Chang Y, Moore M, Atlas SJ. Processes of care, illness severity, and outcomes in the management of community-acquired pneumonia at academic hospitals. Arch Intern Med. 2001; 161:2099104.
  • 15
    Marrie TJ, Wu L. Factors influencing in-hospital mortality in community-acquired pneumonia: a prospective study of patients not initially admitted to the ICU. Chest. 2005; 127:126070.
  • 16
    Silber SH, Garrett C, Singh R, et al. Early administration of antibiotics does not shorten time to clinical stability in patients with moderate-to-severe community-acquired pneumonia. Chest. 2003; 124:1798804.
  • 17
    Drake DE, Cohen A, Cohn J. National hospital antibiotic timing measures for pneumonia and antibiotic overuse. Qual Manag Health Care. 2007; 16:11322.
  • 18
    Fee C, Weber E, Sharpe BA, Nguy M, Quon T, Bookwalter T. JCAHO/CMS core measures for community-acquired pneumonia [letter]. Ann Emerg Med. 2006; 47:505.
  • 19
    Fee C, Weber EJ. Identification of 90% of patients ultimately diagnosed with community-acquired pneumonia within four hours of emergency department arrival may not be feasible. Ann Emerg Med. 2007; 49:5539.
  • 20
    Nicks BA, Manthey DE, Fitch MT. The Centers for Medicare and Medicaid Services (CMS) community-acquired pneumonia core measures lead to unnecessary antibiotic administration by emergency physicians. Acad Emerg Med. 2009; 16:18487.
  • 21
    Pines JM. Profiles in patient safety: Antibiotic timing in pneumonia and pay-for-performance. Acad Emerg Med. 2006; 13:78790.
  • 22
    Pines JM, Hollander JE, Lee H, Everett WW, Uscher-Pines L, Metlay JP. Emergency department operational changes in response to pay-for-performance and antibiotic timing in pneumonia. Acad Emerg Med. 2007; 14:5458.
  • 23
    Welker JA, Huston M, McCue JD. Antibiotic timing and errors in diagnosing pneumonia. Arch Intern Med. 2008; 168:3516.
  • 24
    Hausmann LR, Ibrahim SA, Mehrotra A, et al. Racial and ethnic disparities in pneumonia treatment and mortality. Med Care. 2009; 47:100917.
  • 25
    Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998; 36:827.
  • 26
    Chu YT, Ng YY, Wu SC. Comparison of different comorbidity measures for use with administrative data in predicting short- and long-term mortality. BMC Health Serv Res. 2010; 10:e140.
  • 27
    Southern DA, Quan H, Ghali WA. Comparison of the Elixhauser and Charlson/Deyo methods of comorbidity measurement in administrative data. Med Care. 2004; 42:35560.
  • 28
    Zeger S, Liang K. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986; 42:12130.
  • 29
    Cheng AC, Buising KL. Delayed administration of antibiotics and mortality in patients with community-acquired pneumonia. Ann Emerg Med. 2009; 53:61824.
  • 30
    Waterer GW, Kessler LA, Wunderink RG. Delayed administration of antibiotics and atypical presentation in community-acquired pneumonia. Chest. 2006; 130:115.
  • 31
    Metlay JP, Schulz R, Li YH, et al. Influence of age on symptoms at presentation in patients with community-acquired pneumonia. Arch Intern Med. 1997; 157:14539.
  • 32
    Bodi M, Rodriguez A, Sole-Violan J, et al. Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of America guidelines on survival. Clin Infect Dis. 2005; 41:170916.
  • 33
    Jha AK, Li Z, Orav EJ, et al. Care in U.S. hospitals--the Hospital Quality Alliance program. N Engl J Med. 2005; 353:26574.
  • 34
    Fine JM, Fine MJ, Galusha D, Petrillo M, Meehan TP. Patient and hospital characteristics associated with recommended processes of care for elderly patients hospitalized with pneumonia: results from the medicare quality indicator system pneumonia module. Arch Intern Med. 2002; 162:82733.
  • 35
    Ayanian JZ, Weissman JS, Chasan-Taber S, Epstein AM. Quality of care by race and gender for congestive heart failure and pneumonia. Med Care. 1999; 37:12609.
  • 36
    Camp PG, O’Donnell DE, Postma DS. Chronic obstructive pulmonary disease in men and women: myths and reality. Proc Am Thorac Soc. 2009; 6:5358.
  • 37
    Ziss DR, Stowers A, Feild C. Community-acquired pneumonia: compliance with centers for Medicare and Medicaid services, national guidelines, and factors associated with outcome. South Med J. 2003; 96:94959.
  • 38
    Meehan TP, Weingarten SR, Holmboe ES, et al. A statewide initiative to improve the care of hospitalized pneumonia patients: The Connecticut Pneumonia Pathway Project. Am J Med 2001; 111:20310.
  • 39
    Centers for Disease Control and Prevention. ICD-9-CM Official Guidelines for Coding and Reporting. Available at: Accessed Mar 2, 2011.
  • 40
    Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997; 336:24350.